Related Experiment Video
Updated: Jul 11, 2026
07:29
Programmed Electrical Stimulation in Mice
Published on: May 27, 2010
Effects of ethylephrine on the rat atrial pacemaker.
Acta Physiologica Latino Americana
|January 1, 1977
Summary
Ethylephrine acts directly on beta-receptors, showing less power than other sympathomimetic amines. Its effects are enhanced by reserpine and pargyline, and modulated by alpha-receptor activity and monoamine oxidase.
Area of Science:
- Pharmacology
- Cardiovascular Physiology
Background:
- Sympathomimetic amines are crucial in regulating cardiovascular function.
- Understanding the specific mechanisms of action for drugs like ethylephrine is essential for therapeutic applications.
Purpose of the Study:
- To characterize the dose-chronotropic response of ethylephrine in isolated rat atria.
- To investigate the influence of reserpine, pargyline, cocaine, phentolamine, and propranolol on ethylephrine's effects.
Main Methods:
- Isolated rat atria assay.
- Dose-chronotropic response curve analysis.
- Assessment of drug interactions (reserpine, pargyline, cocaine, phentolamine, propranolol).
Main Results:
- Ethylephrine exhibited a typical bell-dome dose-response curve, but was less potent than epinephrine, norepinephrine, or isoproterenol.
- Reserpine pretreatment induced supersensitivity and increased the maximum chronotropic effect.
- Pargyline augmented ethylephrine's accelerating effects.
- Cocaine and phentolamine shifted the curve leftward, indicating interaction.
- Propranolol decelerated ethylephrine's effects and decreased maxima at higher doses.
Conclusions:
- Ethylephrine is a direct-acting sympathomimetic amine with beta-receptor stimulation.
- A degree of alpha-receptor-mediated deceleration is involved.
- Ethylephrine is a substrate for monoamine oxidase (MAO).
